Your browser doesn't support javascript.
Hospitalization costs of coronaviruses diseases in upper-middle-income countries: A systematic review.
Rocha-Filho, César Ramos; Martins, Johnny Wallef Leite; Lucchetta, Rosa Camila; Ramalho, Gabriel Sodré; Trevisani, Giulia Fernandes Moça; da Rocha, Aline Pereira; Pinto, Ana Carolina Pereira Nunes; Reis, Felipe Sebastião de Assis; Ferla, Laura Jantsch; Mastroianni, Patrícia de Carvalho; Correa, Luci; Saconato, Humberto; Trevisani, Virgínia Fernandes Moça.
  • Rocha-Filho CR; Evidence-Based Health Program, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  • Martins JWL; Pharmaceutical Sciences Program, School of Pharmaceutical Sciences, Universidade Estadual de São Paulo, Araraquara, SP, Brazil.
  • Lucchetta RC; Department of Drugs and Medicines, School of Pharmaceutical Sciences, Universidade Estadual de São Paulo, Araraquara, SP, Brazil.
  • Ramalho GS; Department of Sustainability and Social Responsibility, Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brazil.
  • Trevisani GFM; Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  • da Rocha AP; Faculdade de Medicina, Universidade de Santo Amaro, São Paulo, SP, Brazil.
  • Pinto ACPN; Evidence-Based Health Program, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  • Reis FSA; Evidence-Based Health Program, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  • Ferla LJ; Department of Biological and Health Sciences, Universidade Federal do Amapá, Macapá, AP, Brazil.
  • Mastroianni PC; Department of Medical Practices, Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil.
  • Correa L; Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  • Saconato H; Pharmaceutical Sciences Program, School of Pharmaceutical Sciences, Universidade Estadual de São Paulo, Araraquara, SP, Brazil.
  • Trevisani VFM; Department of Drugs and Medicines, School of Pharmaceutical Sciences, Universidade Estadual de São Paulo, Araraquara, SP, Brazil.
PLoS One ; 17(3): e0265003, 2022.
Article in English | MEDLINE | ID: covidwho-1742016
ABSTRACT

BACKGROUND:

COVID-19, SARS and MERS are diseases that present an important health burden worldwide. This situation demands resource allocation to the healthcare system, affecting especially middle- and low-income countries. Thus, identifying the main cost drivers is relevant to optimize patient care and resource allocation.

OBJECTIVE:

To systematically identify and summarize the current status of knowledge on direct medical hospitalization costs of SARS, MERS, or COVID-19 in Upper-Middle-Income Countries.

METHODS:

We conducted a systematic review across seven key databases (PubMed, EMBASE, BVS Portal, CINAHL, CRD library, MedRxiv and Research Square) from database inception to February 2021. Costs extracted were converted into 2021 International Dollars using the Purchasing Power Parity-adjusted. The assessment of quality was based on the protocol by the BMJ and CHEERS. PROSPERO 2020 CRD42020225757.

RESULTS:

No eligible study about SARS or MERS was recovered. For COVID-19, five studies presented cost analysis performed in Brazil, China, Iran, and Turkey. Regarding total direct medical costs, the lowest cost per patient at ward was observed in Turkey ($900.08), while the highest in Brazil ($5,093.38). At ICU, the lowest was in Turkey ($2,984.78), while the highest was in China ($52,432.87). Service care was the most expressive (58% to 88%) cost driver of COVID-19 patients at ward. At ICU, there was no consensus between service care (54% to 87%) and treatment (72% to 81%) as key burdens of total cost.

CONCLUSION:

Our findings elucidate the importance of COVID-19 on health-economic outcomes. The marked heterogeneity among studies leaded to substantially different results and made challenging the comparison of data to estimate pooled results for single countries or regions. Further studies concerning cost estimates from standardized analysis may provide clearer data for a more substantial analysis. This may help care providers and policy makers to organize care for patients in the most efficient way.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Delivery of Health Care / SARS-CoV-2 / COVID-19 / Hospitalization Type of study: Observational study / Prognostic study / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0265003

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Delivery of Health Care / SARS-CoV-2 / COVID-19 / Hospitalization Type of study: Observational study / Prognostic study / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0265003